Organization
Institut Gustav Roussy
1 abstract
Abstract
PRIMROSE: A modular phase 1/2a study of AZD3470, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP deficient advanced solid tumors.Org: ERC Chromatin Remodeling, Institut Gustav Roussy,